These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12434475)

  • 21. Inhibition of experimental autoimmune uveoretinitis by systemic and subconjunctival adenovirus-mediated transfer of the viral IL-10 gene.
    De Kozak Y; Thillaye-Goldenberg B; Naud MC; Da Costa AV; Auriault C; Verwaerde C
    Clin Exp Immunol; 2002 Nov; 130(2):212-23. PubMed ID: 12390308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
    Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
    Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
    Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The immunoregulatory role of local antigen-presenting cells in ocular inflammation].
    Sonoda KH
    Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):700-7. PubMed ID: 16363663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations.
    Takase H; Yu CR; Ham DI; Chan CC; Chen J; Vistica BP; Wawrousek EF; Durum SK; Egwuagu CE; Gery I
    J Leukoc Biol; 2006 Sep; 80(3):538-45. PubMed ID: 16793919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
    Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional immunity of the eye.
    Mochizuki M
    Acta Ophthalmol; 2010 May; 88(3):292-9. PubMed ID: 19900207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo.
    Siepmann K; Biester S; Plsková J; Muckersie E; Duncan L; Forrester JV
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):221-9. PubMed ID: 16741709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunopathogenesis of chronic and relapsing autoimmune uveitis - Lessons from experimental rat models.
    Diedrichs-Möhring M; Kaufmann U; Wildner G
    Prog Retin Eye Res; 2018 Jul; 65():107-126. PubMed ID: 29496590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
    Haq E; Rohrer B; Nath N; Crosson CE; Singh I
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of bucillamine and antigen-presenting cells in experimental autoimmune uveitis in rats.
    Sawa K; Mochizuki M
    Jpn J Ophthalmol; 1997; 41(6):388-95. PubMed ID: 9509306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor.
    Zhang L; Ma J; Takeuchi M; Usui Y; Hattori T; Okunuki Y; Yamakawa N; Kezuka T; Kuroda M; Goto H
    Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2109-17. PubMed ID: 20007828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P2Y2R deficiency attenuates experimental autoimmune uveitis development.
    Relvas LJ; Makhoul M; Dewispelaere R; Caspers L; Communi D; Boeynaems JM; Robaye B; Bruyns C; Willermain F
    PLoS One; 2015; 10(2):e0116518. PubMed ID: 25692550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis.
    Tarrant TK; Silver PB; Wahlsten JL; Rizzo LV; Chan CC; Wiggert B; Caspi RR
    J Exp Med; 1999 Jan; 189(2):219-30. PubMed ID: 9892605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crucial role of P2X
    Takeda A; Yamada H; Hasegawa E; Arima M; Notomi S; Myojin S; Yoshimura T; Hisatomi T; Enaida H; Yanai R; Kimura K; Ishibashi T; Sonoda KH
    Jpn J Ophthalmol; 2018 May; 62(3):398-406. PubMed ID: 29572578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
    Laliotou B; Duncan L; Dick AD
    J Autoimmun; 1999 May; 12(3):145-55. PubMed ID: 10222024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.
    Uhlig KM; Schülke S; Scheuplein VA; Malczyk AH; Reusch J; Kugelmann S; Muth A; Koch V; Hutzler S; Bodmer BS; Schambach A; Buchholz CJ; Waibler Z; Scheurer S; Mühlebach MD
    J Virol; 2015 Sep; 89(17):9044-60. PubMed ID: 26085166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of exogenous interleukin-2, interleukin-23 on differentiation of IRBP 1-20-specific T cells toward Th1 and Th17 and comparison of the pathogenicity of IRBP 1-20-specific T cells].
    Li Y; Cui Y; Bi HS; Wang Y; Li J; Wang XR
    Zhonghua Yan Ke Za Zhi; 2013 Mar; 49(3):224-9. PubMed ID: 23866703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.